BMY vs GPRO · P/E 17, rev $24.46B vs rev $204.0M
Bristol-Myers Squibb Company (BMY) versus GoPro Inc (GPRO) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
GoPro Inc (GPRO) is a consumer electronics company listed on NASDAQ.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported GPRO revenue for 2026-06-30 was $204.0M. Net income was -$131.8M. GPRO currently screens at market cap $136.8M.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. GPRO currently screens at market cap $136.8M.
Not investment advice. Open the BMY and GPRO stock pages for the full models.
Not investment advice.